Pharmacokinetic Interaction Between Fingolimod and Carbamazepine in Healthy Subjects

This open‐label, single‐sequence study in healthy subjects investigated the effects of steady‐state carbamazepine on the pharmacokinetic (PK) profile of a single 2‐mg dose of fingolimod. In period 1, a single oral dose of fingolimod 2 mg (day 1) was followed by PK and safety assessments up to 36 day...

Descripción completa

Detalles Bibliográficos
Autores principales: David, Olivier J., Behrje, Rhett, Pal, Parasar, Hara, Hisanori, Lates, Christian D., Schmouder, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099239/
https://www.ncbi.nlm.nih.gov/pubmed/29694732
http://dx.doi.org/10.1002/cpdd.459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099239/
https://www.ncbi.nlm.nih.gov/pubmed/29694732
http://dx.doi.org/10.1002/cpdd.459

Ejemplares similares